Advertisement
U.S. Markets open in 4 hrs 46 mins

Molecular Partners AG (MOLN.SW)

Swiss - Swiss Delayed Price. Currency in CHF
5.27+0.07 (+1.35%)
As of 09:00AM CET. Market open.
Currency in CHF

Valuation Measures4

Market Cap (intraday) 191.55M
Enterprise Value 50.68M
Trailing P/E N/A
Forward P/E 13.62
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)28.61
Price/Book (mrq)1.38
Enterprise Value/Revenue 8.44
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.54
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 39.50
52 Week Low 33.11
50-Day Moving Average 34.66
200-Day Moving Average 34.56

Share Statistics

Avg Vol (3 month) 323.73k
Avg Vol (10 day) 332.81k
Shares Outstanding 536.84M
Implied Shares Outstanding 6N/A
Float 86.46M
% Held by Insiders 112.35%
% Held by Institutions 144.72%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Sep 30, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-2,142.29%

Management Effectiveness

Return on Assets (ttm)-21.17%
Return on Equity (ttm)-37.37%

Income Statement

Revenue (ttm)6M
Revenue Per Share (ttm)0.18
Quarterly Revenue Growth (yoy)-73.20%
Gross Profit (ttm)N/A
EBITDA -62.16M
Net Income Avi to Common (ttm)-62.59M
Diluted EPS (ttm)-1.89
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)143.62M
Total Cash Per Share (mrq)4.33
Total Debt (mrq)2.75M
Total Debt/Equity (mrq)1.98
Current Ratio (mrq)14.33
Book Value Per Share (mrq)4.18

Cash Flow Statement

Operating Cash Flow (ttm)-62.04M
Levered Free Cash Flow (ttm)-38.46M